Last reviewed · How we verify
NCT04687891
Transabdominal Versus Transvaginal Ultrasound to Assess the Thickness of the Lower Uterine Segment.
trial testing transabdominal ultrasound and transvaginal ultrasound in Trans Abdominal Ultrasound in 130 participants. Completed in 31 December 2020.
30 December 2020
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 130 |
| Start date | 1 May 2020 |
| Primary completion | 30 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- transabdominal ultrasound and transvaginal ultrasound
Conditions studied
- Trans Abdominal Ultrasound — all drugs for Trans Abdominal Ultrasound →
- Transvaginal Ultrasound — all drugs for Transvaginal Ultrasound →
- Lower Uterine Segment Thickness — all drugs for Lower Uterine Segment Thickness →
Sponsor
Cairo University
Who can join
Adults 20 to 40, female only, with Trans Abdominal Ultrasound or Transvaginal Ultrasound. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
aims to determine the accuracy of measurement of the LUS thickness by trans-abdominal and transvaginal ultrasound at term pregnancy in comparison to the actual thickness of LUS measured with manual caliper measurement during cesarean delivery. Study hypothesis: In women with previous cesarean delivery, determination of the LUS thickness can be done by trans-abdominal and transvaginal ultrasound at term pregnancy and compared to the actual thickness of LUS measured with a manual caliper at cesarean delivery. Study question: considering transabdominal \& transvaginal ultrasound, which of them would be more accurate in the assessment of LUS thickness?
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Transabdominal versus transvaginal ultrasound to assess the thickness of lower uterine segment at term in women with previous cesarean section.
Nagy Afifi A, Ahmed Taymour M, Mamdouh El-Khayat W. · · 2022 · cited 7× · PMID 35203047 · DOI 10.1016/j.ejogrb.2022.01.027
Verify or expand the search:
- PubMed search for NCT04687891
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04687891 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 29 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04687891.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing